Key points are not available for this paper at this time.
The ras gene product (p21) is a GTP-binding protein and has been thought to transduce signals regulating proliferation or differentiation of cells. Like other GTP-binding proteins, p21.GTP is an active conformation, which can transduce the signals downstream, whereas p21.GDP is an inactive one. Recently, we have shown that p21.GTP levels increased in cells treated with fetal bovine serum or platelet-derived growth factor to initiate DNA synthesis. In this paper, we report that epidermal growth factor can also increase the amounts of p21.GTP in the cells. Effects of epidermal growth factor and platelet-derived growth factor are not additive. In contrast, mutant Val12p21, which has transforming activity, responded neither to platelet-derived growth factor nor to epidermal growth factor. We also found that the ratio of p21.GTP to p21.GDP increased 3- to 4-fold in transformants carrying activated erbB-2/neu or v-src oncogenes. These results strongly suggest an important role of p21 in transduction of signals for both normal proliferation and malignant transformation through growth factor receptors with tyrosine kinase activity or related oncogene products.
Building similarity graph...
Analyzing shared references across papers
Loading...
Takaya Satoh
Osaka Prefecture University
Michiko Endo
Yokohama City University
Masato Nakafuku
Cincinnati Children's Hospital Medical Center
Proceedings of the National Academy of Sciences
The University of Tokyo
Building similarity graph...
Analyzing shared references across papers
Loading...
Satoh et al. (Mon,) studied this question.
synapsesocial.com/papers/6a1537b0b03a896dfa81fc34 — DOI: https://doi.org/10.1073/pnas.87.20.7926
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: